Xiamen Amoytop Biotech Co., Ltd. (688278.SS) SHH

Currency In CNY

AD

Valuation

Market Cap34.05B
Enterprise Value33.68B
P/E Ratio21.2
PEG Ratio-1.88
Price/Sales Ratio4.5
Price/Book Ratio5.34
Enterprise/Revenue4.83
Enterprise/EBITDA16.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.21
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.14
Return On Equity0.25

Income Statement

Revenue3.7B
Revenue/Share9.94
Gross Profit3.44B
EBITDA1.32B
Net Income1.03B
Diluted EPS2.52

Balance Sheet

Total Cash2.24B
Total Cash/Share5.64
Total Debt2.2B
Total Debt/Equity0.68
Current Ratio7.35
Book Value Per Share8.14

Price History

52-Week Change-42.87
52-Week High85.57
52-Week Low41.11
Moving Average 50 Days49.55
Moving Average 200 Days58.86

Statistics

Average Volume3.46M
Shares Outstanding408.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield1.43
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD